AFIB Acutus Medical

Acutus Medical to Cancel Third Quarter 2023 Conference Call

Acutus Medical to Cancel Third Quarter 2023 Conference Call

CARLSBAD, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced that, following the Company’s announcement of its strategic realignment of resources and corporate restructuring and release of its third quarter results on November 8, 2023, the Company will no longer hold its third quarter results conference call and webcast which was previously scheduled for Monday, November 13, 2023.

About Acutus Medical, Inc.

Acutus is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. Founded in 2011, Acutus is based in Carlsbad, California.



Investor Contact:
Chad Hollister

Acutus Medical, Inc.
D: 442-232-6080


EN
10/11/2023

Underlying

AFIBAcutus Medical

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Acutus Medical

 PRESS RELEASE
Free
AFIB ACUTUS MEDICAL

Acutus Medical Reports Full Year 2024 Financial Results

Acutus Medical Reports Full Year 2024 Financial Results CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the full year of 2024. Recent Highlights: 2024 Revenue from Continuing Operations of $20.2 million grew 181% year-over-year, from $7.2 million last year.Operating loss for continuing operations was $0.1 million, compared to 11.7 million last year.Recorded $10.8 million in gain on sale of business, an increase of 19% compared to last year.Cash, cash equivalents, marketable securities and restri...

March 24, 2025 1 EN
 PRESS RELEASE
Free
AFIB ACUTUS MEDICAL

Acutus Medical Announces Operational Downsizing

Acutus Medical Announces Operational Downsizing CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and operational downsizing. Dr. Shaden Marzouk, Chairperson of the Board of Directors of Acutus, commented, “Following an extensive strategic review by the Company’s Board of Directors, we are taking the hard but necessary steps to reduce the size of our organization while complying with our remaining obligations to Medtronic for the production of left-heart access products.” Takeo ...

December 4, 2024 1 EN
 PRESS RELEASE
Free
AFIB ACUTUS MEDICAL

Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial R...

Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results CARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the third quarter and year-to-date of 2024. Recent Highlights: Third quarter revenue from Continuing Operations of $5.3 million grew 156% year-over-year, from $2.1 million in the same quarter last year.Operating income for continuing operations was $0.1 million, an improvement of 119% compared to the same period last year.Recorded $2.4 million in gain on sale of bus...

November 14, 2024 1 EN
 PRESS RELEASE
Free
AFIB ACUTUS MEDICAL

Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial ...

Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results CARLSBAD, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the second quarter and year-to-date of 2024. Recent Highlights: Second quarter revenue from Continuing Operations of $4.1 million grew 172% year-over-year, from $1.5 million in the same quarter last year.Operating expenses for continuing operations were $2.2 million, a reduction of 47% compared to the same period last year.Recorded $2.9 million in gain on sale of business,...

August 8, 2024 1 EN
 PRESS RELEASE
Free
AFIB ACUTUS MEDICAL

Acutus Medical Reports First Quarter 2024 Financial Results

Acutus Medical Reports First Quarter 2024 Financial Results CARLSBAD, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the first quarter of 2024. Recent Highlights: First quarter revenue from Continuing Operations of $3.6 million grew 192% year-over-year, from $1.2 million in the same quarter last year..Operating expenses for continuing operations were $3.3 million, a reduction of 38% compared to the same period last year.Recorded $2.8 million in gain on sale of business, an increase of 131% compared to ...

May 9, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch